| Aspira Womens Health is engaged in the discovery, development and commercialization of diagnostic and bio-analytical solutions. Co.'s products and related services include: OVA1, a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at high risk of having a malignant ovarian tumor prior to planned surgery; Overa, a biomarker panel; OVA1PLUS, a service offering combining its OVA1 and Overa products; and ASPiRA GenetiX, a genetic test for women's health diseases, which is focused on detecting hereditary breast and ovarian cancer syndrome; and Carrier screening, genetic screening for carriers of disease. We show 3 historical shares outstanding datapoints in our coverage of AWH's shares outstanding history.|
Understanding the changing numbers of AWH shares outstanding — and
comprehending the concept of differing number of shares outstanding in general comparing companies like AWH versus peers —
is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies.
Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history.
With this page we aim to empower investors researching AWH by allowing them to research AWH shares outstanding history
as well as any other stock in our coverage universe.